These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23105138)

  • 21. Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells.
    Herrmann T; Maryanski JL; Romero P; Fleischer B; MacDonald HR
    J Immunol; 1990 Feb; 144(4):1181-6. PubMed ID: 1968075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular and molecular basis of human gamma delta T cell activation. Role of accessory molecules in alloactivation.
    Takamizawa M; Fagnoni F; Mehta-Damani A; Rivas A; Engleman EG
    J Clin Invest; 1995 Jan; 95(1):296-303. PubMed ID: 7814628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpaca (
    Fichtner AS; Karunakaran MM; Gu S; Boughter CT; Borowska MT; Starick L; Nöhren A; Göbel TW; Adams EJ; Herrmann T
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6697-6707. PubMed ID: 32139608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) Treg.
    Han WG; Schuurhuis DH; Fu N; Camps M; van Duivenvoorde LM; Louis-Plence P; Franken KL; Huizinga TW; Melief CJ; Toes RE; Ossendorp F
    Eur J Immunol; 2009 Jul; 39(7):1765-73. PubMed ID: 19544486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4+Foxp3+ regulatory T cell expansion induced by antigen-driven interaction with intestinal epithelial cells independent of local dendritic cells.
    Westendorf AM; Fleissner D; Groebe L; Jung S; Gruber AD; Hansen W; Buer J
    Gut; 2009 Feb; 58(2):211-9. PubMed ID: 18832523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The density of the class II MHC T cell receptor ligand influences IFN-gamma/IL-4 ratios in immune responses in vivo.
    DiMolfetto L; Neal HA; Wu A; Reilly C; Lo D
    Cell Immunol; 1998 Jan; 183(1):70-9. PubMed ID: 9578721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
    Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
    Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
    J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
    Dennig D; Yan Y; Ferguson K; O'Reilly RJ
    Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
    Wacholtz MC; Patel SS; Lipsky PE
    J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major histocompatibility antigen class II expressing resting porcine T lymphocytes are potent antigen-presenting cells in mixed leukocyte culture.
    Saalmüller A; Maurer S
    Immunobiology; 1994 Feb; 190(1-2):23-34. PubMed ID: 8082885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Professional antigen-presentation function by human gammadelta T Cells.
    Brandes M; Willimann K; Moser B
    Science; 2005 Jul; 309(5732):264-8. PubMed ID: 15933162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monocytes and gammadelta T cells: close encounters in microbial infection.
    Eberl M; Moser B
    Trends Immunol; 2009 Dec; 30(12):562-8. PubMed ID: 19853512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
    Clement LT; Tedder TF; Gartland GL
    J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Superantigen-mediated human monocyte-T lymphocyte interactions are associated with an MHC class II-, TCR/CD3-, and CD4-dependent mobilization of calcium in monocytes.
    Damaj B; Mourad W; Naccache PH
    J Immunol; 1992 Sep; 149(5):1497-503. PubMed ID: 1380531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired ability of MHC class II-/- dendritic cells to provide tumor protection is rescued by CD40 ligation.
    Hermans IF; Ritchie DS; Daish A; Yang J; Kehry MR; Ronchese F
    J Immunol; 1999 Jul; 163(1):77-81. PubMed ID: 10384102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressive activity of Vδ2
    Schilbach K; Krickeberg N; Kaißer C; Mingram S; Kind J; Siegers GM; Hashimoto H
    Cancer Immunol Immunother; 2020 Apr; 69(4):593-610. PubMed ID: 31982940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.